PFIZER, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.44 USD | +1.54% |
|
+0.99% | -1.22% |
ETFs positioned on Pfizer, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.51% | 29 M€ | -.--% | - | |
| 0.50% | 786 M€ | -.--% | ||
| 0.50% | 23 M€ | -.--% | - | |
| 0.50% | 206 M€ | -.--% | ||
| 0.50% | 34 M€ | +11.93% | - | |
| 0.45% | 571 M€ | +6.88% | - | |
| 0.45% | 3 M€ | +5.91% | - | |
| 0.44% | 48 M€ | +0.40% | - | |
| 0.43% | 205 M€ | -.--% | ||
| 0.41% | 0 M€ | 0.00% | - | |
| 0.41% | 391 M€ | +8.67% | - | |
| 0.41% | 14 M€ | +16.19% | - | |
| 0.39% | 1 M€ | +3.03% | - | |
| 0.39% | 9 M€ | +9.07% | - | |
| 0.38% | 34 M€ | +8.24% | - | |
| 0.37% | 169 M€ | -0.77% | - | |
| 0.37% | 1,166 M€ | +0.26% | ||
| 0.37% | 607 M€ | +0.05% | ||
| 0.34% | 45 M€ | 0.00% | - | |
| 0.33% | 112 M€ | +4.06% | - | |
| 0.32% | 35 M€ | +8.15% | - | |
| 0.30% | 23 M€ | +7.25% | - | |
| 0.29% | 1 M€ | -.--% | - | |
| 0.28% | 306 M€ | +5.68% | - | |
| 0.28% | 39 M€ | +5.63% | - |
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.01
USD
Average target price
31.94
USD
Spread / Average Target
+14.02%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -1.22% | 159B | |
| +29.98% | 684B | |
| +30.34% | 568B | |
| -3.52% | 361B | |
| +18.59% | 329B | |
| +4.07% | 284B | |
| +16.21% | 240B | |
| +9.66% | 208B | |
| -6.83% | 200B | |
| +7.09% | 166B |
- Stock Market
- Equities
- PFE Stock
- Funds and ETFs Pfizer, Inc.